Diabetes, Obesity and Metabolism First published: 19 January 2021 Victoria Garfield PhD Abstract Aim To understand the relationship between HbA1c and brain health across the entire glycaemic spectrum. Materials and Methods We used data from the UK Biobank cohort consisting of 500,000 individuals aged 40–69 years. HbA1c and diabetes diagnosis were used to define baseline glycaemic […]
Ronald Grisanti D.C., D.A.B.C.O., D.A.C.B.N., M.S. A recent patient was concerned that despite watching her diet and taking her diabetes medication her hemoglobin A1C (HbA1c) keeps going up. Remember, HbA1c is a lab test that shows the average level of blood sugar (glucose) over the previous 3 months. It shows how well you are controlling […]
Diabetes Research and Clinical Practice | November 04, 2019 Shi Z and Badi Abou-Samra A – In this cross-sectional study, researchers explored the connection between serum magnesium and diabetes and hypertension among Qatari adults. Data were used from 9,693 Qatari participants (aged ≥ 20 years) from the Qatar Biobank (QBB) Study. Using serum magnesium as […]
Diabetic Medicine — McArdle PD, et al. | November 16, 2018 Using data collected via search of the Medline, EMBASE and CINAHL databases (between 1976 and April 2018), researchers studied the impact of carbohydrate restriction on glycemic control among individuals with type 2 diabetes. A total of 1,402 randomized controlled trials were identified, ow which […]
Ronald Grisanti D.C., D.A.B.C.O., D.A.C.B.N., M.S. A recent patient was concerned that despite watching her diet and taking her diabetes medication her hemoglobin A1C (HbA1c) keeps going up. Remember, HbA1c is a lab test that shows the average level of blood sugar (glucose) over the previous 3 months. It shows how well you are controlling […]
Jennifer Abbasi JAMA. 2018;319(23):2367-2369. doi:10.1001/jama.2018.5420 Medical organizations are at odds over new guidance that recommends easing hemoglobin A1C (HbA1c) targets for patients with type 2 diabetes. The updated guidance statement from the American College of Physicians (ACP), which focuses on glycemic control with medications, says clinicians should personalize goals and aim to achieve an HbA1c level of between 7% […]
Acta Diabetologica pp 1–10 | Cite as Kassaian, N., Feizi, A., Aminorroaya, A. et al. Acta Diabetol (2018). https://doi.org/10.1007/s00592-018-1175-2 Abstract Aims Probiotics and/or prebiotics could be a promising approach to improve metabolic disorders by favorably modifying the gut microbial composition. Objectives To assess the effects of probiotics and synbiotic on glycemic indices in prediabetic individuals […]
MARCH 19, 2018 Reuters Health News Prediabetes may increase patients’ risk for heart and kidney disease, a US study suggests. As reported in The Lancet Diabetes and Endocrinology, online February 28, researchers examined a nationally representative sample of 27,971 adults surveyed in four waves from 1988 to 1994, 1999 to 2004, 2005 to 2010, and 2011 […]
by Jeff Minerd, Contributing Writer, MedPage Today March 05, 2018 New type 2 diabetes guidelines from the American College of Physicians (ACP) recommend less-intensive blood sugar control for most patients, with a glycated hemoglobin (HbA1c) target between 7% and 8%. “Studies have not consistently shown that intensive glycemic control to HbA1c levels below 7% reduces […]
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study Cite this article as: Hallberg, S.J., McKenzie, A.L., Williams, P.T. et al. Diabetes Ther (2018). https://doi.org/10.1007/s13300-018-0373-9 Abstract Introduction Carbohydrate restriction markedly improves glycemic control in patients with type 2 diabetes (T2D) but […]
Diabetes Research and Clinical Practice Volume 135, January 2018, Pages 45-49 Manhal Izzy Highlights Higher glycated hemoglobin level is associated with slower gastric motility. Higher glycated hemoglobin level can be associated with worse gastroparetic symptoms. Intensive glycemic control might prevent or improve diabetic gastroparesis. Abstract Aim To investigate the association between glycemic control represented by glycated hemoglobin (HbA1c) level and the […]
March 20, 2017 Diabetes Care TAKE-HOME MESSAGE This analysis of data from 7333 adults (≥65 years) from the Third National Health and Nutrition Examination Survey (NHANES III) and Continuous NHANES was made to determine if HbA1c levels correlate with mortality in patients with diabetes. With a median follow-up of 8.9 years, 4729 (64.5%) of participants […]
February 08, 2017 TUESDAY, Feb. 7, 2017 (HealthDay News) — For individuals without diabetes, glycated hemoglobin (HbA1c) is associated with accelerated progression of aortic stiffness, according to a study published online Jan. 25 in Diabetes Care. Carmel M. McEniery, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues examined the impact of […]
The Journal of Alternative and Complementary Medicine To cite this article: Dick William R., Fletcher Emily A., and Shah Sachin A.. The Journal of Alternative and Complementary Medicine. June 2016, 22(6): 450-457. doi:10.1089/acm.2015.0122. Published in Volume: 22 Issue 6: June 17, 2016 ABSTRACT Purpose: Diabetes mellitus is a global epidemic and one of the leading […]
Posted on November 9, 2015 by Cleveland HeartLab Many prevention specialists believe that we are not diagnosing diabetes early enough if we wait for hemoglobin A1c(HbA1c) levels to reach ≥ 6.5%. Filepe Moura and colleagues sought to find out if there was a relationship between HbA1c levels in non-diabetic ST-elevation myocardial infarction (STEMI) patients and […]
09.08.2015 Stroke Rounds: HbA1C Has Modest Impact on CVD Risk Adding hemoglobin A1C (HbA1c) to conventional cardiovascular risk assessment had only a modest effect on post-test, 10-year atherosclerotic cardiovascular disease (ASCVD) risk, researchers reported. Using data from the 2010-2011 National Health and Nutrition Examination Surveys (NHANES), Mark J. Pletcher, MD, MPH, of the University of […]
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension Journal of Ethnopharmacology , 12/12/2014 Lan J, et al. – This study indicates that berberine has comparable therapeutic effect on Type 2 DM, hyperlipidemia and hypertension with no serious side effect. Considering the relatively low cost […]
November 25, 2014 The New England Journal of Medicine TAKE-HOME MESSAGE The authors of this registry-based observational study of a Swedish population of patients with type 1 diabetes (N = 33,915) determined the excess risk for death according to level of glycemic control. After a mean follow-up of 8 years, 8% of patients with diabetes […]
Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial Prof Hertzel C Gerstein MD The Lancet, Volume 384, Issue 9958, Pages 1936 – 1941, 29 November 2014 Summary Background Hyperglycaemia could substantially increase the risk of ischaemic heart disease in patients with type 2 diabetes. We […]